Seminars in Hematology

(The H4-Index of Seminars in Hematology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
Memory-like natural killer cells for cancer immunotherapy53
Iron metabolism in infections: Focus on COVID-1950
Toward a pathophysiology inspired treatment of VEXAS syndrome43
Epidemiology of VITT34
Aplastic anemia: Pathophysiology33
Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)32
Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome32
Platelet-activating anti-PF4 disorders: An overview30
Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)29
Thrombotic manifestations of VEXAS syndrome28
Mechanisms of cellular iron sensing, regulation of erythropoiesis and mitochondrial iron utilization25
Genetics of somatic auto-inflammatory disorders24
Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?23
VEXAS within the spectrum of rheumatologic disease22
Monitoring MRD in ALL: Methodologies, technical aspects and optimal time points for measurement21
Modulating NK cell metabolism for cancer immunotherapy20
Shaping the bone through iron and iron-related proteins18
Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity17
20 years of Hepcidin: How far we have come17